Literature DB >> 16140699

Preventable adverse events in infants hospitalized with bronchiolitis.

Sarah C McBride1, Vincent W Chiang, Donald A Goldmann, Christopher P Landrigan.   

Abstract

OBJECTIVE: To determine the incidence of preventable adverse events (AEs) and near misses (NMs) among infants hospitalized for bronchiolitis at a pediatric tertiary care hospital and the impact of these errors on hospital length of stay (LOS).
METHODS: We studied 143 infants with bronchiolitis, ages 0 to 12 months, admitted from December 2002 to April 2003. Using prospective chart review and staff reports, we captured medical errors and AEs. Each event was classified as a (1) preventable AE, (2) nonpreventable AE, (3) intercepted NM, (4) nonintercepted NM, or (5) error with little or no potential for harm.
RESULTS: Of 143 patients, 15 (10%) suffered an AE or NM. The incidence of preventable AEs was 10 per 100 admissions. We found a higher incidence of preventable AEs and NMs among critically ill patients (CIPs) compared with non-CIPs (68 vs 5 per 100 admissions, respectively), making the absolute risk of an AE or NM 14 times more likely in CIPs. Mean LOS was significantly longer for CIPs with at least 1 AE (9.1 +/- 8.8 days) than for CIPs without AEs (2.9 +/- 1.5 days). Mean LOS was not significantly different between non-CIPs who did (3.8 +/- 2.6 days) and did not (4.2 +/- 5.0 days) experience an AE.
CONCLUSIONS: Preventable AEs occur frequently among patients admitted for bronchiolitis, especially those who are critically ill. CIPs who suffer AEs during their hospitalization have longer hospital LOSs. Future studies should investigate error-prevention strategies with a focus on those patients with severe disease.

Entities:  

Mesh:

Year:  2005        PMID: 16140699     DOI: 10.1542/peds.2004-2387

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Discharge Criteria for Bronchiolitis: An Unmet Need.

Authors:  Cristina Garcia-Mauriño; Melissa Moore-Clingenpeel; Rebecca Wallihan; Katalin Koranyi; Bavani Rajah; Tiffany Shirk; Maria Vegh; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2018-06       Impact factor: 2.129

2.  Paediatric critical incident analysis: lessons learnt on analysis, recommendations and implementation.

Authors:  Cynthia van der Starre; Monique van Dijk; Ada van den Bos; Dick Tibboel
Journal:  Eur J Pediatr       Date:  2014-05-31       Impact factor: 3.183

3.  Safe and efficient discharge in bronchiolitis: how do we get there?

Authors:  Patrick W Brady; Amanda C Schondelmeyer
Journal:  J Hosp Med       Date:  2015-01-28       Impact factor: 2.960

4.  Herpes simplex virus testing and hospital length of stay in neonates and young infants.

Authors:  Samir S Shah; Jessica Volk; Zeinab Mohamad; Richard L Hodinka; Joseph J Zorc
Journal:  J Pediatr       Date:  2010-02-10       Impact factor: 4.406

5.  Prevalence of Continuous Pulse Oximetry Monitoring in Hospitalized Children With Bronchiolitis Not Requiring Supplemental Oxygen.

Authors:  Christopher P Bonafide; Rui Xiao; Patrick W Brady; Christopher P Landrigan; Canita Brent; Courtney Benjamin Wolk; Amanda P Bettencourt; Lisa McLeod; Frances Barg; Rinad S Beidas; Amanda Schondelmeyer
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

6.  Factors associated with iatrogenesis in neonatal intensive care units: an observational multicenter study.

Authors:  Einav Srulovici; Liora Ore; Eric S Shinwell; Shraga Blazer; Shmuel Zangen; Arieh Riskin; David Bader; Amir Kugelman
Journal:  Eur J Pediatr       Date:  2012-07-28       Impact factor: 3.183

7.  EHR-Integrated Monitor Data to Measure Pulse Oximetry Use in Bronchiolitis.

Authors:  Andrew S Kern-Goldberger; Irit R Rasooly; Brooke Luo; Sansanee Craig; Daria F Ferro; Halley Ruppel; Padmavathy Parthasarathy; Nathaniel Sergay; Courtney M Solomon; Kate E Lucey; Naveen Muthu; Christopher P Bonafide
Journal:  Hosp Pediatr       Date:  2021-10

8.  Hospital course and discharge criteria for children hospitalized with bronchiolitis.

Authors:  Jonathan M Mansbach; Sunday Clark; Pedro A Piedra; Charles G Macias; Alan R Schroeder; Brian M Pate; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo
Journal:  J Hosp Med       Date:  2015-01-28       Impact factor: 2.960

9.  Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV).

Authors:  Joseph M Geskey; Neal J Thomas; Gretchen L Brummel
Journal:  Biologics       Date:  2007-03

10.  The impact of adverse events in the intensive care unit on hospital mortality and length of stay.

Authors:  Alan J Forster; Kwadwo Kyeremanteng; Jon Hooper; Kaveh G Shojania; Carl van Walraven
Journal:  BMC Health Serv Res       Date:  2008-12-17       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.